Pseudomyogenic hemangioendothelioma rarely arises in bone. WWTR1-FOSB fusion gene is rarely reported in PMHE of bone. Currently, fusion genes can be used as diagnostic markers in PMHE; however, their prognostic and therapeutic significance is unclear.
CITATION STYLE
Murshed, K. A., Torres-Mora, J., ElSayed, A. M., Ammar, A., & Al-Bozom, I. (2021). Pseudomyogenic hemangioendothelioma of bone with rare WWTR1-FOSB fusion gene: Case report and literature review. Clinical Case Reports, 9(3), 1494–1499. https://doi.org/10.1002/ccr3.3808
Mendeley helps you to discover research relevant for your work.